These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32312598)

  • 41. Long noncoding RNA TCL6 binds to miR-106a-5p to regulate hepatocellular carcinoma cells through PI3K/AKT signaling pathway.
    Luo LH; Jin M; Wang LQ; Xu GJ; Lin ZY; Yu DD; Yang SL; Ran RZ; Wu G; Zhang T
    J Cell Physiol; 2020 Sep; 235(9):6154-6166. PubMed ID: 32020591
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1α, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma.
    Xiang ZL; Zeng ZC; Fan J; Tang ZY; Zeng HY; Gao DM
    Clin Cancer Res; 2011 Aug; 17(16):5463-72. PubMed ID: 21712445
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway.
    Zhang M; Liu S; Chua MS; Li H; Luo D; Wang S; Zhang S; Han B; Sun C
    Cell Death Dis; 2019 Aug; 10(8):612. PubMed ID: 31406106
    [TBL] [Abstract][Full Text] [Related]  

  • 44. YKL-40 expression in human hepatocellular carcinoma: a potential biomarker?
    Xiao XQ; Hassanein T; Li QF; Liu W; Zheng YH; Chen J
    Hepatobiliary Pancreat Dis Int; 2011 Dec; 10(6):605-10. PubMed ID: 22146624
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MiR-155 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells through the activation of PI3K/SGK3/β-catenin signaling pathways.
    Kong X; Liu F; Gao J
    Oncotarget; 2016 Oct; 7(40):66051-66060. PubMed ID: 27602769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
    Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K
    J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma.
    Dong ZZ; Yao DF; Yao DB; Wu XH; Wu W; Qiu LW; Jiang DR; Zhu JH; Meng XY
    World J Gastroenterol; 2005 Aug; 11(30):4655-60. PubMed ID: 16094705
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
    Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma.
    Li XM; Tang ZY; Zhou G; Lui YK; Ye SL
    J Exp Clin Cancer Res; 1998 Mar; 17(1):13-7. PubMed ID: 9646228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma.
    Bamodu OA; Chang HL; Ong JR; Lee WH; Yeh CT; Tsai JT
    Cells; 2020 Mar; 9(3):. PubMed ID: 32197467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Myeloid differentiation factor 88 promotes growth and metastasis of human hepatocellular carcinoma.
    Liang B; Chen R; Wang T; Cao L; Liu Y; Yin F; Zhu M; Fan X; Liang Y; Zhang L; Guo Y; Zhao J
    Clin Cancer Res; 2013 Jun; 19(11):2905-16. PubMed ID: 23549880
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients.
    Wang RY; Chen L; Chen HY; Hu L; Li L; Sun HY; Jiang F; Zhao J; Liu GM; Tang J; Chen CY; Yang YC; Chang YX; Liu H; Zhang J; Yang Y; Huang G; Shen F; Wu MC; Zhou WP; Wang HY
    Gastroenterology; 2013 Dec; 145(6):1436-48.e1-12. PubMed ID: 23933603
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LINC00963 promotes hepatocellular carcinoma progression by activating PI3K/AKT pathway.
    Wu JH; Tian XY; An QM; Guan XY; Hao CY
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1645-1652. PubMed ID: 29630107
    [TBL] [Abstract][Full Text] [Related]  

  • 54. cIAP2 via NF-κB signalling affects cell proliferation and invasion in hepatocellular carcinoma.
    Jiang XJ; Chen ZW; Zhao JF; Liao CX; Cai QH; Lin J
    Life Sci; 2021 Feb; 266():118867. PubMed ID: 33310033
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease.
    Bahnassy AA; Zekri AR; El-Bastawisy A; Fawzy A; Shetta M; Hussein N; Omran D; Ahmed AA; El-Labbody SS
    World J Gastroenterol; 2014 Dec; 20(48):18240-8. PubMed ID: 25561791
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA‑9‑5p downregulates Klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway.
    Dong X; Wang F; Xue Y; Lin Z; Song W; Yang N; Li Q
    Int J Mol Med; 2019 Mar; 43(3):1417-1429. PubMed ID: 30664155
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Down-Regulated NRSN2 Promotes Cell Proliferation and Survival Through PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma.
    Wang X; Han L; Zhang J; Xia Q
    Dig Dis Sci; 2015 Oct; 60(10):3011-8. PubMed ID: 26055238
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lysyl Oxidase Is Predictive of Unfavorable Outcomes and Essential for Regulation of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma.
    Zhu J; Huang S; Wu G; Huang C; Li X; Chen Z; Zhao L; Zhao Y
    Dig Dis Sci; 2015 Oct; 60(10):3019-31. PubMed ID: 26048020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Expression of liver-type fatty acid-binding protein and vascular endothelial growth factor and their correlation in human hepatocellular carcinoma].
    Dong LH; Li H; Wang F; Li FQ; Zhou HY; Yang HJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):318-21. PubMed ID: 17425983
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Liquid biopsies for hepatocellular carcinoma.
    Su YH; Kim AK; Jain S
    Transl Res; 2018 Nov; 201():84-97. PubMed ID: 30056068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.